Follow
Wenyan Jiang
Wenyan Jiang
Assistant Professor, Mount Sinai School of Medicine, Columbia University, Rockefeller University
Verified email at mssm.edu - Homepage
Title
Cited by
Cited by
Year
Multiplex genome engineering using CRISPR/Cas systems
L Cong, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, ...
Science 339 (6121), 819-823, 2013
188532013
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini
Nature biotechnology 31 (3), 233-239, 2013
31162013
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
D Bikard, W Jiang, P Samai, A Hochschild, F Zhang, LA Marraffini
Nucleic acids research 41 (15), 7429-7437, 2013
14412013
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
D Bikard, CW Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146-1150, 2014
9952014
Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity
P Samai, N Pyenson, W Jiang, GW Goldberg, A Hatoum-Aslan, ...
Cell 161 (5), 1164-1174, 2015
4972015
Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting
GW Goldberg, W Jiang, D Bikard, LA Marraffini
Nature 514 (7524), 633-637, 2014
3132014
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ...
US Patent App. 14/105,035, 2014
2812014
Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids
W Jiang, I Maniv, F Arain, Y Wang, BR Levin, LA Marraffini
PLoS genetics 9 (9), e1003844, 2013
2612013
CRISPR-Cas: new tools for genetic manipulations from bacterial immunity systems
W Jiang, LA Marraffini
Annual review of microbiology 69 (1), 209-228, 2015
2532015
Degradation of phage transcripts by CRISPR-associated RNases enables type III CRISPR-Cas immunity
W Jiang, P Samai, LA Marraffini
Cell 164 (4), 710-721, 2016
2392016
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang
US Patent App. 14/497,627, 2015
2282015
CRISPR-Cas component systems, methods and compositions for sequence manipulation
F Zhang, DO BIKARD, L Cong, DBT Cox, P Hsu, W Jiang, LIN Shauiliang, ...
2242014
CRISPR–Cas systems exploit viral DNA injection to establish and maintain adaptive immunity
JW Modell, W Jiang, LA Marraffini
Nature 544 (7648), 101-104, 2017
1672017
Prokaryotic single-cell RNA sequencing by in situ combinatorial indexing
SB Blattman, W Jiang, P Oikonomou, S Tavazoie
Nature microbiology 5 (10), 1192-1201, 2020
1622020
A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs
A Hatoum-Aslan, P Samai, I Maniv, W Jiang, LA Marraffini
Journal of Biological Chemistry 288 (39), 27888-27897, 2013
1392013
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang, NE Sanjana
US Patent App. 15/887,377, 2018
1302018
CRISPR-assisted editing of bacterial genomes
W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini
Nature biotechnology 31 (3), 233, 2013
1262013
Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases
D Bikard, C Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146, 2014
672014
Impact of different target sequences on type III CRISPR-Cas immunity
I Maniv, W Jiang, D Bikard, LA Marraffini
Journal of bacteriology 198 (6), 941-950, 2016
582016
Comprehensive genome-wide perturbations via CRISPR adaptation reveal complex genetics of antibiotic sensitivity
W Jiang, P Oikonomou, S Tavazoie
Cell 180 (5), 1002-1017. e31, 2020
492020
The system can't perform the operation now. Try again later.
Articles 1–20